UK Regulator Wants More Patient Input At Pre-Authorization Stage

The MHRA is taking steps to embed “meaningful and impactful” patient involvement across its regulatory pathways.

Patient group
The MHRA wants more input from patients (Shutterstock)

More from Review Pathways

More from United Kingdom